drugset / Trial / NCT02859025

Concomitant Use of Buccal Fat Pad Derived Cells and Autogenous Bone in Alveolar Cleft Osteoplasty

NCT02859025 ↗

Phase 1 Completed 10 enrolled Shahid Beheshti University of Medical Sciences
RandomizedParallel-groupOpen-labelTreatment

Summary

Our aim was to combine regenerative techniques with bone grafting in human models to increase predictability and survival of reconstructed tissue. The MSCs in this study were derived from an intra oral fat source (BFP) and were cultured over natural bovine bone mineral granules and delivered within the lateral ramus cortical bone plate (LRCP)to treat human alveolar cleft defects.

Timeline

Start
2015-01
Primary completion
2016-01
Completion
2016-02

Drugs

EvaluationDrugModalityDoseRoute
Subject BFPSCs Cell therapy — —

Indications